Skip to content
  • Facebook
  • Twitter
  • linkedin
Open Access Publisher of Medical and Social Science Journals
Openventio Publishers
  • Home
  • About us
    • Vision/Mission
    • Open Access
    • Editorial Assessment and Peer Review Process
  • Journals
  • Editorial Guidelines
    • For Authors
    • For Editors
    • For Reviewers
    • For Readers
    • For Librarians
  • Submit Manuscript
  • Contact Us
  • More
    • Advertisement
    • Reprints
    • Privacy Policy
    • FAQs
Home
/
journal-index
/
Cancer Studies and Molecular Medicine – Open Journal (CSMMOJ)
/
Archive-csmmoj

Volume 5

October, 2019

Volume 5, Issue 1

[ Download PDF ]

Volume 4

November, 2018

Volume 4, Issue 1

[ Download PDF ]

Volume 3

December, 2017

Volume 3, Issue 2

[ Download PDF ]

January, 2017

Volume 3, Issue 1

[ Download PDF ]

Volume 2

August, 2015

Volume 2, Issue 1

[ Download PDF ]

December, 2015

Volume 2, Issue 2

[ Download PDF ]

Volume 1

December, 2014

Volume 1, Issue 1

[ Download PDF ]

×

Article in press

  • 2020, March

    editorial

    Pathology Hiding in Plain Sight: The NF1 Plasma MembraneOpen Access

    Vincent M. Riccardi*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-6-e008
    Provisional PDF287.00 KB 287.00 KB
    Full-Text (HTML)

  • 2020, May

    opinion

    Cancer DynamicsOpen Access

    Daniel Gandia* and Cecilia Suárez
    DOI: http://dx.doi.org/10.17140/CSMMOJ-6-130
    Provisional PDF298.99 KB 298.99 KB
    Full-Text (HTML)

  • 2020, September

    review

    Anastasis: Cell Survival MechanismOpen Access

    Abolaji S. Olagunju*, Folashade G. Olorunfemi, John O. Teibo and Abiodun M. Adewolu
    DOI: http://dx.doi.org/10.17140/CSMMOJ-6-131
    Provisional PDF515.40 KB 515.40 KB
    Full-Text (HTML)
    Abstract [+]

    Equilibrium between cell survival and death is important for normal cell homeostasis and development and also for inhibiting pathologies particularly cancer. Anastasis is a natural cell recovery phenomenon that rescues cells from the brink of death or a mechanism by which cells recuperate from apoptotic lesions and return to its normal active and functioning state. Programmed cell death (apoptosis) was known to be an intrinsically irreversible cascade that commits cells to a rapid destruction. However,
    recent studies have demonstrated the possibility of recovering dying cells even at the late stages. Anastasis uses the usual pro-metastatic and pro-survival factors to inhibit apoptotic progression. Epithelial mesenchymal transition (EMT) activation and its related modulators is not only linked with cellular metastasis and survivability but also widely associated with the stemness of cancer cells.
    Keywords
    Anastasis; Programmed cell death; Cancer; Pro-metastatic factor; Pro-survival factor; Genetic instability; Cell cycle arrest.


NOTE: The DOIs of the In-Press Articles will only function after the final publication of the articles and once they are uploaded to the Current Issues.
×

Current Issue

  • 2019, April

    editorial

    Engaging African Americans in Breast Cancer Prevention Strategies: A Partnership Between a Community Cancer Center and the African American Community in DelawareOpen Access

    Jennifer Sims-Mourtada*, Zohra Ali-Khan Catts, Patricia Swanson and Nora Katurakes
    DOI:
    PDF266.76 KB 266.76 KB
    Full-Text (HTML)
    Full-Text (HTML)

  • 2019, May

    original research

    Deep-Ultraviolet Raman Spectroscopy for Cancer Diagnostics: A Feasibility Study with Cell Lines and TissuesOpen Access

    Nicole M. Ralbovsky, Vladimir Egorov, Eugene Moskovets, Paromita Dey, Bijan K. Dey and Igor K. Lednev*
    DOI:
    PDF593.90 KB 593.90 KB
    Full-Text (HTML)
    Full-Text (HTML)

  • 2019, August

    review

    Anticancer Natural Products: A ReviewOpen Access

    Ranwa A. Elrayess and Heba N. Gad El-Hak*
    DOI:
    PDF478.35 KB 478.35 KB
    Full-Text (HTML)
    Full-Text (HTML)
    Abstract [+]

    Historically, natural products played a forceful role in human treatment ailments. Nowadays, natural products include a large part of current pharmaceutical agents, mostly in the field of cancer therapy. The main aim of this review is to provide a comprehensive summary of the most known natural product used as anticancer globally, including various other natural products. Many of these natural product appears to act through an anticancer mechanism. Overall, natural product research is a vigorous tool to discover novel biologically active components with unique mechanisms of action. Given the diversity of nature, it is sensible to indicate that chemical leads can be produced that are able to interact with most therapeutic targets. This review creates a solid foundation for further study these natural products with additional research and study.

    Keywords

    Anticancer; Natural product; Plant compounds; Marine flora; Microorganisms; Venom.


  • 2019, August

    case series

    Oligo-Metastatic Carcinoma Cervix: A Few Do Extremely WellOpen Access

    Pallavi Nair and Francis V. James*
    DOI:
    PDF316.45 KB 316.45 KB
    Full-Text (HTML)
    Full-Text (HTML)
    Abstract [+]

    The consequence of metastatic carcinoma cervix is regarded to be poor. We present three patients with carcinoma cervix who relapsed in the paraaortic nodes, lungs and vertebra. All of them had oligometastatic disease and were treated with chemotherapy to the lung lesion and radiotherapy to the bone lesion and paraaortic nodes. After more than 5-years they are disease free and on regular follow-up.

    Keywords

    Carcinoma; Cervix; Oligometastasis; Paraaortic lymph nodes; Chemoradiation; Chemotherapy.


  • 2019, October

    opinion

    The Phenotype Landscape of Cancer in the Genotype EraOpen Access

    Daniel Gandia*
    DOI:
    PDF250.06 KB 250.06 KB
    Full-Text (HTML)
    Full-Text (HTML)

×

Previous Issue

  • 2018, January

    case study

    Dosimetric Characterization of an Abscopal Response in a Patient With Oligometastatic Melanoma Undergoing Concurrent Treatment With Pembrolizumab and Stereotactic Body Radiotherapy (SBRT)Open Access

    Jennifer Sims-Mourtada*, Serguei Casteneda, David Huang, John McGlade, Sunjay Shah, Lindsay Romak, Adam Raben and Firas Mourtada
    DOI: http://dx.doi.org/10.17140/CSMMOJ-4-121
    PDF355.47 KB 355.47 KB
    Full-Text (HTML)

  • 2018, February

    case report

    A Rare Case of a Urachal Mucinous Cystic Tumour of Low Malignant PotentialOpen Access

    Kanchan K. Palial*, Bob Yang, Philip J.S. Charlesworth, Charles E. Lewis, Lisa Browning and Clare Verrill
    DOI: http://dx.doi.org/10.17140/CSMMOJ-4-122
    PDF677.26 KB 677.26 KB
    Full-Text (HTML)

  • 2018, May

    editorial

    The Emerging Role of p27 in Development of DiseasesOpen Access

    Qiwei Yang* and Ayman Al-Hendy
    DOI: http://dx.doi.org/10.17140/CSMMOJ-4-e006
    PDF262.31 KB 262.31 KB
    Full-Text (HTML)

  • 2018, August

    illustration

    Bilateral Symmetric Thalamic Metastasis in a Patient with Small Cell Lung CancerOpen Access

    Takeshi Saraya*, Chie Shimura, Sayuki Inaoka and Hajime Takizawa
    DOI: http://dx.doi.org/10.17140/CSMMOJ-4-123
    PDF472.87 KB 472.87 KB
    Full-Text (HTML)

  • 2018, August

    illustration

    A Case of Choroidal Metastasis from Small-Cell Lung CarcinomaOpen Access

    Manami Inoue, Takeshi Saraya*, Miku Oda, Masachika Fujiwara and Hajime Takizawa
    DOI: http://dx.doi.org/10.17140/CSMMOJ-4-124
    PDF597.15 KB 597.15 KB
    Full-Text (HTML)

  • 2018, September

    systematic review

    The Emerging Spectrum of Early Life Exposure-Related Inflammation and Epigenetic TherapyOpen Access

    Qiwei Yang*, Mohamed Ali, Abdeljabar El Andaloussi, Ayman Al-Hendy
    DOI: http://dx.doi.org/10.17140/CSMMOJ-4-125
    PDF509.82 KB 509.82 KB
    Full-Text (HTML)

    • Home
    • Authors Instructions
    • Submit Manuscript
    • Reviewer Registration
    • Contact Us
    • Editorial Panel
    • Article in press
    • Current issue
    • Previous issue
    • Archive
    • Archive

    Connect with us



    Editor-in-Chief

    Pradeep Garg, PhD

    Executive Director Center for Molecular Imaging and Therapy Biomedical Research Foundation of Northwest Louisiana 1505 Kings Highway Shreveport, LA 71103, USA  

    Associate Editors

    Jennifer Sims-Mourtada, PhD

    Senior Clinical Scientist Center for Translational Cancer Research Helen F. Graham Cancer Center Christiana Care Health System Newark, DE, USA

    Our editorial team


    Advertisement

    About Openventio

    Openventio Publishers is licensed under a Creative Commons Attribution 4.0 International License.
    based on the work at www.openventio.org

    Quick Links
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement
    Find Us

    Suite#B013, Nexus Business Center
    Block-B, Level 2, Road no. 3
    Film Nagar, Hyderabad
    Telangana State, India

    Openventio Publishers
    • Facebook
    • Twitter
    • linkedin
    © 2014 - 2021 Openventio Publishers. All Rights Reserved.
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement